Furthermore, we detected the activation FAK-MAPK pathway, and applied the FAK inhibitor PF-573228 and the ERK inhibitor Magnolin to treat the T-ALL cells. The gene discussed is PTK2; the disease is acute lymphoblastic leukemia.